Date: 2020-07-09
Titre: Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis
Auteurs: Bissonnette R, Diaz A, Estrada Y, Guttman-Yassky E, He H, Jack C, Krueger JG, Louis M, Maari C, Pavel AB, Saint-Cyr Proulx E, Wu J, Zhang N
Categorie: Eczema,Psoriasis
Lire cette publication sur PUBMED
Date: 2020-04-25
Titre: The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
Auteurs: Armstrong J, Beck LA, Bieber T, Bissonnette R, Chavda R, DeLozier AM, Dubost-Brama A, Dutronc Y, Eichenfield L, Feldman SR, Frey S, Guttman E, Janes JM, Joubert Y, Kabashima K, King B, Klekotka P, Lin CY, Mallbris L, Martel P, Menter A, Milutinovic M, Nickoloff B, Nunes F, Paller A, Parneix A, Paul C, Reich K, Seyger M, Siegfried E, Silverberg JI, Simpson E, Stingl G, Sun L, Teixeira HD, van de Kerkhof P, Yosipovitch G
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2020-03-14
Titre: ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation.
Auteurs: Bissonnette R, Dong C, Galand C, Geha RS, Leyva-Castillo JM, Mashiko S, McGurk A, McKenzie ANJ, Sarfati M, Ziegler SF
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2020-01-05
Titre: Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.
Auteurs: Beck LA, Bieber T, Bissonnette R, Brinker DR, Cardillo T, Costanzo A, DeLozier AM, Eichenfield LF, Galimberti R, Gamalo M, Guttman-Yassky E, Janes JM, Kabashima K, King BA, Lacour JP, Nunes FP, Paller AS, Reich K, Silverberg JI, Simpson EL, Spelman L, Thyssen JP, Tsunemi Y, Wollenberg A
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2019-12-26
Titre: Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.
Auteurs: Akinlade B, Ardeleanu M, Beck LA, Beissert S, Bissonnette R, Chan KC, Chen Z, Davis JD, Eckert L, Ferrandiz C, Gadkari A, Graham NMH, Hultsch T, Kawashima M, Lacour JP, Pirozzi G, Rajadhyaksha M, Simpson EL, Smith CH, Stahl N, Staudinger H, Thaçi D, Worm M, Yancopoulos GD
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2019-12-03
Titre: Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.
Auteurs: Bissonnette R, Bitton A, Bressler B, Gooderham M, Haraoui B, Ho V, Jamal S, Kumar D, Marshall JK, Papp KA, Pope JE, Steinhart AH, Vinh DC, Wade J
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2019-11-13
Titre: Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial
Auteurs: Bissonnette R, Diaz A, Estrada YD, Guttman-Yassky E, Pavel AB, Ports WC, Purohit VS, Saint-Cyr Proulx E, Vlahos B, Vranic I, Werth JL, Zang C, Zielinski MA
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-11-09
Titre: Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy: Residual Psoriatic Plaques After Treatment
Auteurs: Bissonnette R, Bi Y, Cao X, Edelmayer RM, Garcet S, Huang SM, Kaimal V, Kannan AK, Krueger JG, Liu Z, Li X, Maari C, Mashiko S, Olson LM, Saint-Cyr Proulx E, Salte K, Sarfati M, Smith KM., Wang J, Wetter JB
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2019-10-04
Titre: Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis
Auteurs: Bissonnette R, Del Duca E, Denis L, Dubin C, Estrada YD, Gupta S, Guttman-Yassky E, Kim HJ, Krueger JG, Pavel AB, Peng X, Rao N, Song T, Xu H, Zammit DJ, Zhang N
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2019-10-02
Titre: Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial
Auteurs: Banfield C, Beebe JS, Bissonnette R, Forman SB, Gooderham MJ, Papacharalambous J, Peeva E, Vincent MS, Zhang W, Zhu L
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-09-10
Titre: Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis
Auteurs: Bissonnette R, Gooderham M, Hong CH
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-08-12
Titre: Incidence of Cardiovascular Events Among Tildrakizumab-Treated Patients with Moderate to Severe Plaque Psoriasis: Pooled Data from 3 Large Randomised Clinical Trials
Auteurs: Bissonnette R, Fernández-Peñas P, Mendelsohn AM, Menter A, Puig L, Rozzo SJ
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2019-07-30
Titre: Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
Auteurs: Akinlade B, Ardeleanu M, Beck LA, Bissonnette R, Blauvelt A, Bouaziz JD, Chen Z, Davis JD, de Bruin-Weller M, Deleuran M, Eckert L, Foley P, Forman S, Gadkari A, Gelfand JM, Graham NMH, Hide M, Hussain I, Pirozzi G, Rajadhyaksha M, Reich K, Schuttelaar MLA, Sher L, Soong W, Staudinger H, Thaçi D, Wang C
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-07-26
Titre: Oral JAK/SYK-inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in atopic dermatitis.
Auteurs: Bissonnette R, Del Duca E, Denis L, Dubin C, Estrada Y, Gupta S, Guttman-Yassky E, Kim HJ, Krueger JG, Pavel AB, Peng X, Rao N, Song T, Xu H, Zammit DJ, Zhang N
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-06-25
Titre: IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.
Auteurs: Ardeleanu M, Bissonnette R, Callewaert C, Gallo RL, Graham NMH, Guttman-Yassky E, Hamilton JD, Hultsch T, Knight R, Kosciolek T, Kotol P, Krueger J, Menter A, Nakatsuji T, Pirozzi G, Silverberg JI, Vrbanac A
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-06-17
Titre: Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Auteurs: Barankin B, Bissonnette R, Chavda R, Dreno B, Gagné-Henley A, Kerrouche N, Lynde C, Tan J
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2019-05-03
Titre: Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals.
Auteurs: Bissonnette R, Brezinski Wallace E, Del Duca E, Dubin C, Estrada YD, Guttman-Yassky E, Jack C, Krueger JG, Maari C, Pavel AB, Peng X, Song T, St-Cyr Proulx E, Xu H
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2019-03-29
Titre: The Oral JAK/SYK Inhibitor ASN002 Demonstrates Efficacy and Improves Associated Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Randomised, Double-Blind, Placebo-Controlled Study.
Auteurs: Bissonnette R, Maari C, Forman S, Bhatia N, Lee M, Fowler J, Tyring S, Pariser D, Sofen H, Dhawan S, Zook M, Zammit DJ, Usansky H, Denis L, Rao N, Song T, Pavel AB, Guttman-Yassky E
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-03-12
Titre: Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement.
Auteurs: Bissonnette R, Cork MJ, Guttman-Yassky E, Irvine AD, Leshem YA, Paller AS, Paul C, Silverberg JI
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-02-10
Titre: GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis.
Auteurs: Guttman-Yassky E, Pavel AB, Zhou L, Estrada YD, Zhang N, Xu H, Peng X, Wen HC, Govas P, Gudi G, Ca V, Fang H, Salhi Y, Back J, Reddy V, Bissonnette R, Maari C, Grossman F, Wolff G
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2019-02-09
Titre: Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study.
Auteurs: Reich K, Rich P, Maari C, Bissonnette R, Leonardi C, Menter A, Igarashi A, Klekotka P, Patel D, Li J, Tuttle J, Morgan-Cox M, Edson-Heredia E, Friedrich S, Papp K; AMAF investigators
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2019-01-08
Titre: Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis.
Auteurs: Robbins K, Bissonnette R, Maeda-Chubachi T, Ye L, Peppers J, Gallagher K, Kraus JE
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2019-01-01
Titre: Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
Auteurs: Bieber T, Bissonnette R, Brown SJ, Dhar S, Eyerich K, Guttman-Yassky E, Hijnen DJ, Irvine A, Paller AS, Perez White BE, Reynolds NJ, Tanaka RJ, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-11-23
Titre: Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.
Auteurs: Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2018-11-16
Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis.
Auteurs: Hong CH, Gooderham MJ, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-11-16
Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document.
Auteurs: Gooderham MJ, Hong CH, Albrecht L, Bissonnette R, Dhadwal G, Gniadecki R, Grewal P, Kirchhof MG, Landells I, Lansang P, Lynde CW, Papp KA, Poulin Y, Sussman G, Turchin I, Wiseman M, Yeung J
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-11-16
Titre: Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis.
Auteurs: Gooderham MJ, Bissonnette R, Grewal P, Lansang P, Papp KA, Hong CH
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-10-17
Titre: The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
Auteurs: Guttman-Yassky E, Hanifin JM, Boguniewicz M, Wollenberg A, Bissonnette R, Purohit V, Kilty I, Tallman AM, Zielinski MA
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-09-19
Titre: Ultraviolet B induced immunosuppression is not associated with RANKL upregulation in human skin.
Auteurs: Saint-Cyr Proulx E, Mashiko S, Maari C, Bolduc C, Nigen S, Sarfati M, Bissonnette R
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2018-09-06
Titre: The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.
Auteurs: Tan J, Bissonnette R, Gratton D, Kerrouche N, Canosa JM
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2018-09-05
Titre: Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients.
Auteurs:
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-05-21
Titre: Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.
Auteurs: Valenzuela F, Korman NJ, Bissonnette R, Bakos N, Tsai TF, Harper MK, Ports WC, Tan H, Tallman A, Valdez H, Gardner AC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2018-05-10
Titre: Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled Phase 3b Study of Patients with Moderate-to-Severe Genital Psoriasis.
Auteurs:
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2018-04-19
Titre: Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Auteurs: Dréno B, Bissonnette R, Gagné-Henley A, Barankin B, Lynde C, Kerrouche N, Tan J
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2018-03-19
Titre: Effect of short-term liver X receptor activation on epidermal barrier features in mild to moderate atopic dermatitis: A randomized controlled trial.
Auteurs: Czarnowicki T, Dohlman AB, Malik K, Antonini D, Bissonnette R, Chan TC, Zhou L, Wen HC, Estrada Y, Xu H, Bryson C, Shen J, Lala D, Ma'ayan A, McGeehan G, Gregg R, Guttman-Yassky E
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2018-02-14
Titre: Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study).
Auteurs: Bissonnette R, Luger T, Thaçi D, Toth D, Lacombe A, Xia S, Mazur R, Patekar M, Charef P, Milutinovic M, Leonardi C, Mrowietz U
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2018-02-01
Titre: Topical Vitamin E Cream Does Not Prevent Visible Light-Induced Pigmentation.
Auteurs: Mereniuk A, Marchessault P, Maari C, Bolduc C, Bissonnette R
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2018-02-01
Titre: Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study.
Auteurs: Bissonnette R, Vasist LS, Bullman JN, Collingwood T, Chen G, Maeda-Chubachi T
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2018-02-01
Titre: JAK inhibitors appear to have a bright future in the treatment of atopic dermatitis.
Auteurs: Bissonnette R
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2017-11-15
Titre: Apremilast for the treatment of moderate to severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
Auteurs: Bissonnette R, Haydey R, Rosoph L, Lynde CW, Bukhalo M, Fowler J, Delorme I, Gagné-Henley A, Gooderham M, Poulin Y, Barber K, Jenkin P, Landells I, Pariser D
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-10-21
Titre: A Phase 2a Randomized Controlled Study to Evaluate the Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topically Applied Umeclidinium in Subjects with Primary Axillary Hyperhidrosis
Auteurs: Nasir A, Bissonnette R, Maari C, DuBois J, Pene Dumitrescu T, Haddad J, Yamaguchi Y, Dalessandro M
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2017-10-01
Titre: Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis
Auteurs: Bissonnette R, Kerdel F, Naldi L, Papp K, Galindo C, Langholff W, Tang KL, Szapary P, Fakharzadeh S, Srivastava B, Goyal K, Gottlieb AB
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-10-01
Titre: Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasis
Auteurs: Bissonnette R, Tamaz R, Bolduc C, Maari C, Robillard C, Nigen S, Delorme I, Lynde C
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-08-29
Titre: Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
Auteurs: Bissonnette R, Bourcier M, Gooderham M, Hong CH, Landells I, Lynde C, Papp K, Poulin Y, Vender R, Wiseman MC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-08-01
Titre: The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis
Auteurs: Merola JF, Bleakman AP, Gottlieb AB, Menter A, Naegeli AN, Bissonnette R, Guenther L, Sullivan J, Meeuwis K, See K, Duffin KC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-07-31
Titre: Topical treatment of psoriasis: questionnaire results on topical therapy accessibility and in?uence of body surface area on usage
Auteurs: Bissonnette R, Carvalho AVE, Iversen L, Kirby B, Kleyn CE, Lange MM, Lynde CW, van de Kerkhof PC, van der Walt JM, Wu JJ
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-07-15
Titre: Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis
Auteurs: Mashiko S, Mehta H, Bissonnette R, Sarfati M
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2017-07-01
Titre: Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy
Auteurs: Jack C, Mashiko S, Arbour N, Bissonnette R, Sarfati M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-06-05
Titre: Secukinumab Sustains Good Efficacy and Favourable Safety in Moderate to Severe Psoriasis up to 3 Years of Treatment: Results from A Double-Blind Extension Study
Auteurs: Bissonnette R, Luger T, Thaçi D, Toth D, Messina I, You R, Guana A, Fox T, Papavassilis C, Gilloteau I, Mrowietz U
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-06-01
Titre: Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular Erythema
Auteurs: Tan J, Bourdès V, Bissonnette R, Petit B Eng L, Reynier P, Khammari A, Dreno B
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2017-04-03
Titre: Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.
Auteurs: Dreno B, Tan J, Rivier M, Martel P, Bissonnette R
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2017-03-17
Titre: Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis.
Auteurs: Bissonnette R, Cademartiti F, Maffei E, Tardif JC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-03-09
Titre: TNF-alpha antagonist and vascular inflammation in patients with psoriasis vulgaris: a randomized placebo-controlled study.
Auteurs: Bissonnette R, Harel F, Krueger JG, Guertin MC, Chabot-Blanchet M, Gonzalez J, Maari C, Delorme I, Lynde CW, Tardif JC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-03-07
Titre: Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data.
Auteurs: Strober B, Leonardi C, Papp KA, Mrowietz U, Ohtsuki M, Bissonnette R, Ferris LK, Paul C, Lebwohl M, Braun DK, Mallbris L, Wilhelm S, Xu W, Ljungberg A, Acharya N, Reich K
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-02-24
Titre: Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Auteurs: Guttman-Yassky E, Ungar B, Malik K, Dickstein D, Suprun M, Estrada YD, Xu H, Peng X, Oliva M, Todd D, Labuda T, Suarez-Farinas M, Bissonnette R
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2017-01-08
Titre: Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway.
Auteurs: Bissonnette R, Fuentes-Duculan J, Mashiko S, Li X, Bonifacio KM, Cueto I, Suárez-Fariñas M, Maari C, Bolduc C, Nigen S, Sarfati M, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2017-01-07
Titre: Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study.
Auteurs: Bissonnette R, Poulin Y, Drew J, Hofland H, Tan J
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2016-12-06
Titre: Use of Lesion Response Rate in Actinic Keratosis Trials.
Auteurs: Szeimies RM, Atanasov P, Bissonnette R
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
Date: 2016-11-17
Titre: Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.
Auteurs: Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2016-11-13
Titre: The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
Auteurs: Kim J, Bissonnette R, Lee J, Correa da Rosa J, Suárez-Fariñas M, Lowes MA, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-10-03
Titre: Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
Auteurs: Papp KA, Bissonnette R, Gooderham M, Feldman SR, Iversen L, Soung J, Draelos Z, Mamolo C, Purohit V, Wang C, Ports WC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-08-27
Titre: A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
Auteurs: Bissonnette R, Luchi M, Fidelus-Gort R, Jackson S, Zhang H, Flores R, Newton R, Scherle P, Yeleswaram S, Chen X, Menter A
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-07-30
Titre: Identification of key research needs for topical therapy treatment of psoriasis - a consensus paper by the International Psoriasis Council
Auteurs: Wu JJ, Lynde CW, Kleyn CE, Iversen L, van der Walt JM, Carvalho A, Kirby B, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-07-16
Titre: Topical tofacitinib for atopic dermatitis: A Phase 2a randomised trial
Auteurs: Bissonnette R, Papp KA, Poulin Y, Gooderham M, Raman M, Mallbris L, Wang C, Purohit V, Mamolo C, Papacharalambous J, Ports WC
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2016-07-07
Titre: Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis
Auteurs: Bissonnette R, Pariser DM, Wasel NR, Goncalves J, Day RM, Chen R, Sebastian M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-07-02
Titre: Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
Auteurs: Bissonnette R, Suárez-Fariñas M, Li X, Bonifacio KM, Brodmerkel C, Fuentes-Duculan J, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-05-20
Titre: Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity
Auteurs: Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Gulliver WP, Haraoui B, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-05-13
Titre: The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes
Auteurs: Kim J, Bissonnette R, Lee J, Correa da Rosa J, Suárez-Fariñas M, Lowes MA, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-05-07
Titre: Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).
Auteurs: Strober BE, Bissonnette R, Fiorentino D, Kimball AB, Naldi L, Shear NH, Goyal K, Fakharzadeh S, Calabro S, Langholff W, You Y, Galindo C, Lee S, Lebwohl MG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-05-06
Titre: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
Auteurs: Bissonnette R, Suárez-Fariñas M, Li X, Bonifacio KM, Brodmerkel C, Fuentes-Duculan J, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2016-05-04
Titre: Dr. Roubille, et al reply
Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFARLANE A, Fleming P, Siu S, Kraft J, Lynde C, Pope JE, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2016-04-06
Titre: Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agent
Auteurs: Yamauchi PS, Bissonnette R, Teixeira HD, Valdecantos WC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-08-14
Titre: Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.
Auteurs: Ports WC, Feldman SR, Gupta P, Tan H, Johnson TR, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-07-15
Titre: Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-07-09
Titre: A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
Auteurs: Gordon KB, Duffin KC, Bissonnette R, Prinz JC, Wasfi Y, Li S, Shen YK, Szapary P, Randazzo B, Reich K
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-05-16
Titre: Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE).
Auteurs: Thaçi D, Humeniuk J, Frambach Y, Bissonnette R, Goodman JJ, Shevade S, Gong Y, Papavassilis C; STATURE study group
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-05-08
Titre: Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.
Auteurs:
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-05-01
Titre: Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials
Auteurs: Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2015-04-02
Titre: Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
Auteurs: Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H, Gupta P, Mallbris L, Wolk R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-03-24
Titre: IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies.
Auteurs: Blauvelt A, Lebwohl MG, Bissonnette R
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2015-03-16
Titre: Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Auteurs: Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-03-09
Titre: Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers.
Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2015-02-28
Titre: A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)
Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Toole J, Vieira A, Poulin-Costello M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-01-21
Titre: Improvements in patient-reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE.
Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Garces K, Toole J, Poulin-Costello M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-01-20
Titre: Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.
Auteurs: Bissonnette R, Maari C, Barber K, Lynde CW, Vender R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2015-01-05
Titre: The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Auteurs: Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2014-12-10
Titre: Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review.
Auteurs: Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2014-10-01
Titre: Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial.
Auteurs: Bissonnette R, Nigen S, Langley RG, Lynde CW, Tan J, Fuentes-Duculan J, Krueger JG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2014-08-28
Titre: Changes in serum free testosterone, sleep patterns, and 5-alpha-reductase type I activity influence changes in sebum excretion in female subjects.
Auteurs: Bissonnette R, Risch JE, McElwee KJ, Marchessault P, Bolduc C, Nigen S, Maari C
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2014-08-26
Titre: Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis.
Auteurs: Tan J, Maari C, Nigen S, Bolduc C, Bissonnette R
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2014-07-01
Titre: A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE).
Auteurs: Papp KA, Barber K, Bissonnette R, Bourcier M, Lynde CW, Poulin Y, Shelton J, Toole J, Vieira A, Poulin-Costello M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2014-06-01
Titre: Treatment of notalgia paresthetica with botulinum toxin A: a double-blind randomized controlled trial.
Auteurs: Maari C, Marchessault P, Bissonnette R
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2013-12-01
Titre: Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study.
Auteurs: Kimball AB, Papp KA, Wasfi Y, Chan D, Bissonnette R, Sofen H, Yeilding N, Li S, Szapary P, Gordon KB; PHOENIX 1 Investigators
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2013-11-01
Titre: Risk of myocardial infarction in Canadian patients with psoriasis: a retrospective cohort study.
Auteurs: Levesque A, Lachaine J, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2013-07-16
Titre: A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.
Auteurs: Ports WC, Khan S, Lan S, Lamba M, Bolduc C, Bissonnette R, Papp K
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2013-04-13
Titre: Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy.
Auteurs: Basset-Seguin N, Bissonnette R, Girard C, Haedersdal M, Lear JT, Paul C, Piaserico S
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2013-01-01
Titre: Effects of the tumor necrosis factor-? antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.
Auteurs: Bissonnette R, Tardif JC, Harel F, Pressacco J, Bolduc C, Guertin MC
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-12-26
Titre: Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial.
Auteurs: Bissonnette R, Bolduc C, Maari C, Nigen S, Webster JM, Tang L, Lyle M
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-12-06
Titre: Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
Auteurs: Bissonnette R, Bolduc C, Maari C, Nigen S
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
Date: 2012-10-28
Titre: Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption.
Auteurs: Bissonnette R, Nigen S, Bolduc C
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2012-09-26
Titre: Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology.
Auteurs: Braathen LR, Morton CA, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P, Sidoroff A, Wulf HC, Szeimies RM
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2012-09-19
Titre: Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial.
Auteurs: Maari C, Bolduc C, Nigen S, Marchessault P, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-08-23
Titre: A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.
Auteurs: Lynde CW, Gupta AK, Guenther L, Poulin Y, Levesque A, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-08-11
Titre: A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
Auteurs: Lui H, Gulliver W, Tan J, Hong CH, Hull P, Shear NH, Paradiso-Hardy F, Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-07-16
Titre: Safety and efficacy of adalimumab for the treatment of severe alopecia areata: case series of three patients.
Auteurs: Bolduc C, Bissonnette R
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2012-06-26
Titre: Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology.
Auteurs: Wiegell SR, Wulf HC, Szeimies RM, Basset-Seguin N, Bissonnette R, Gerritsen MJ, Gilaberte Y, Calzavara-Pinton P, Morton CA, Sidoroff A, Braathen LR
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
Date: 2012-04-16
Titre: Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial.
Auteurs: Bissonnette R, Poulin Y, Zhou Y, Tan J, Hong HC, Webster J, Ip W, Tang L, Lyle M
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2012-02-26
Titre: Psoriasis: Why Does it Come With a Greater Risk of Heart Attack and Stroke?
Auteurs: Bissonnette R
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2012-02-06
Titre: Assessment of the long-term safety and effectiveness of etanercept for the treatment of psoriasis in an adult population.
Auteurs: Papp KA, Poulin Y, Bissonnette R, Bourcier M, Toth D, Rosoph L, Poulin-Costello M, Setterfield M, Syrotuik J
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2011-12-25
Titre: Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study.
Auteurs: Bissonnette R, Poulin Y, Guenther L, Lynde CW, Bolduc C, Nigen S
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2011-11-08
Titre: Fatigue and quality of sleep in patients with immune-mediated inflammatory disease.
Auteurs: Graff LA, Walker JR, Russell AS, Bissonnette R, Bernstein CN
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2011-11-08
Titre: Validity of quality of life measurement tools--from generic to disease-specific.
Auteurs: Wells GA, Russell AS, Haraoui B, Bissonnette R, Ware CF
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2011-11-03
Titre: Socioeconomic burden of immune-mediated inflammatory diseases--focusing on work productivity and disability.
Auteurs: Jacobs P, Bissonnette R, Guenther LC
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2011-09-10
Titre: Randomized trial comparing a chemical peel containing a lipophilic hydroxy acid derivative of salicylic acid with a salicylic acid peel in subjects with comedonal acne.
Auteurs: Levesque A, Hamzavi I, Seite S, Rougier A, Bissonnette R
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2011-08-15
Titre: Support needed to involve psoriasis patients in treatment decisions: survey of dermatologists.
Auteurs: Tan J, Stacey D, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Bhatti S
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2011-05-15
Titre: Short incubation methylaminolevulinate photodynamic therapy without occlusion for the treatment of actinic keratoses
Auteurs: Robert Bissonnette, MD, FRCPC Simon Nigen, MD, FRCPC Chantal Bolduc, MD, FRCPC Catherine Maari, MD, FRCPC
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
Date: 2011-03-03
Titre: An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Auteurs: Dirschka T, Reich K, Bissonnette R, Maares J, Brown T, Diepgen TL
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2010-12-14
Titre: Canadian hand dermatitis management guidelines.
Auteurs: Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2010-11-09
Titre: Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris.
Auteurs: Bissonnette R, Maari C, Nigen S, Provost N, Bolduc C
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2010-10-14
Titre: Treatment decision needs of psoriasis patients: cross-sectional survey.
Auteurs: Tan J, Stacey D, Fung K, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Jackson C, Zhang X
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2010-07-04
Titre: Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies.
Auteurs: Langley RG, Papp K, Bissonnette R, Toth D, Matheson R, Hultquist M, White B
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2010-05-24
Titre: Redefining treatment options in chronic hand eczema (CHE).
Auteurs: Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, Luger T, Lynde C, Maares J, Maibach HI
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2010-05-21
Titre: Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
Auteurs: Poulin Y, Papp K, Bissonnette R, Barber K, Kerrouche N, Villemagne H; Calepso Study Team
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2010-05-20
Titre: Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept.
Auteurs: Bissonnette R, Bolduc C, Poulin Y, Guenther L, Lynde CW, Maari C
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2010-04-14
Titre: Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.
Auteurs: Bissonnette R, Chen G, Bolduc C, Maari C, Lyle M, Tang L, Webster J, Zhou Y
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2010-03-09
Titre: A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
Auteurs: Bissonnette R, Maari C, Provost N, Bolduc C, Nigen S, Rougier A, Seite S
Categorie: Dermatitis (toutes)
Lire cette publication sur PUBMED
Date: 2010-03-06
Titre: A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.
Auteurs: Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White WI, Le C, White B
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2010-02-01
Titre: Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Auteurs: Bissonnette R, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzicka T, Maares J, Brown TC
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2010-01-08
Titre: Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
Auteurs: Poulin Y, Papp K, Bissonnette R, Guenther L, Tan J, Lynde C, Kerrouche N, Villemagne H; CalePso Study Team
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: The next phase of real-world clinical experience with alefacept: the AWARE-2 registry
Auteurs: Searles G, Bissonnette R, Landells I, Shear NH
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: Efficacy outcomes in patients using alefacept in the AWARE study
Auteurs: Landells I, Searles G, Bissonnette R, Shear NH, Vender R, Lui H
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study
Auteurs: Searles G, Bissonnette R, Landells I, Shear NH, Papp K, Lui H
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: Update on alefacept safety
Auteurs: Wexler D, Searles G, Landells I, Shear NH, Bissonnette R, Papp K, Poulin Y, Langley R, Gulliver WP
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study
Auteurs: Searles G, Bissonnette R, Landells I, Shear NH
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2009-12-13
Titre: The AWARE study: methodology and baseline characteristics.
Auteurs: Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2009-10-13
Titre: Safety of conventional systemic agents and biologic agents in the treatment of psoriasis.
Auteurs: Bissonnette R, Ho V, Langley RG
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2009-07-30
Titre: Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
Auteurs: Bissonnette R, Langley RG, Papp K, Matheson R, Toth D, Hultquist M, Geba GP, White B
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2009-03-08
Titre: Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris.
Auteurs: Bissonnette R, Bolduc C, Seité S, Nigen S, Provost N, Maari C, Rougier A
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2008-10-12
Titre: Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis.
Auteurs: Bissonnette R, Nigen S, Bolduc C
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2008-10-07
Titre: Etanercept in the treatment of palmoplantar pustulosis.
Auteurs: Bissonnette R, Poulin Y, Bolduc C, Maari C, Provost N, Syrotuik J, Poulin-Costello CM, Nigen S
Categorie: Autres
Lire cette publication sur PUBMED
Date: 2008-09-15
Titre: Protection afforded by sunscreens containing inorganic sunscreening agents against blue light sensitivity induced by aminolevulinic acid
Auteurs: Bissonnette R, Nigen S, Bolduc C, Méry S, Nocera T
Categorie: Acné
Lire cette publication sur PUBMED
Date: 2008-06-12
Titre: Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.
Auteurs: Rivers JK, Rosoph L, Provost N, Bissonnette R
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
Date: 2008-04-19
Titre: Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study.
Auteurs: Papp K, Bissonnette R, Rosoph L, Wasel N, Lynde CW, Searles G, Shear NH, Huizinga RB, Maksymowych WP
Categorie: Psoriasis
Lire cette publication sur PUBMED
Date: 2008-04-15
Titre: Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Auteurs:
Categorie: Eczema
Lire cette publication sur PUBMED
Date: 2004-02-03
Titre: Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond
Auteurs: Bergeron A, Bissonnette R, Liu Y
Categorie: Actinic Keratoses
Lire cette publication sur PUBMED
